The elevated systemic CXCL10 levels are in line with previous data showing that 15 out of 29 patients with SSc-ILD had a statistically significant higher systemic CXCL10 level compared to SSc patients without ILD.21 This evidence concerns the gene CXCL10 and systemic sclerosis.